These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 22812676)
1. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer. Kim HJ; Kim NK; Choi JH; Sohn SY; Kim SW; Jin SM; Jang HW; Suh S; Min YK; Chung JH; Kim SW Clin Endocrinol (Oxf); 2013 Jan; 78(1):134-40. PubMed ID: 22812676 [TBL] [Abstract][Full Text] [Related]
2. Influence of Body Mass Index on the Clinicopathologic Features of Papillary Thyroid Carcinoma. Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):625-632. PubMed ID: 30841713 [TBL] [Abstract][Full Text] [Related]
3. Associations between body mass index and lymph node metastases of patients with papillary thyroid cancer: A retrospective study. Wu C; Wang L; Chen W; Zou S; Yang A Medicine (Baltimore); 2017 Mar; 96(9):e6202. PubMed ID: 28248875 [TBL] [Abstract][Full Text] [Related]
4. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices. Trésallet C; Seman M; Tissier F; Buffet C; Lupinacci RM; Vuarnesson H; Leenhardt L; Menegaux F Surgery; 2014 Nov; 156(5):1145-52. PubMed ID: 24878452 [TBL] [Abstract][Full Text] [Related]
5. Obesity and High Risk Pathological Features of Papillary Thyroid Carcinoma: A Retrospective Analysis of a University Hospital in Pakistan. Zaman SU; Awan MS; Sulaiman MA Gulf J Oncolog; 2018 May; 1(27):6-10. PubMed ID: 30145545 [TBL] [Abstract][Full Text] [Related]
6. Association of Body Mass Index With Clinicopathological Features of Papillary Thyroid Carcinoma: A Retrospective Study. Dong Z; Liu W; Su F; Cheng R Endocr Pract; 2023 Feb; 29(2):83-88. PubMed ID: 36481471 [TBL] [Abstract][Full Text] [Related]
7. Is body mass index relevant to prognosis of papillary thyroid carcinoma? A clinicopathological cohort study. Chung YS; Lee JH; Lee YD Surg Today; 2017 Apr; 47(4):506-512. PubMed ID: 27654453 [TBL] [Abstract][Full Text] [Related]
8. Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior. Nam SY; Shin JH; Han BK; Ko EY; Ko ES; Hahn SY; Chung JH J Clin Endocrinol Metab; 2013 Apr; 98(4):1476-82. PubMed ID: 23463652 [TBL] [Abstract][Full Text] [Related]
9. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma. Shin JH; Ha TK; Park HK; Ahn MS; Kim KH; Bae KB; Kim TH; Choi CS; Kim TK; Bae SK; Kim SH Int J Surg; 2013; 11(9):944-7. PubMed ID: 23820062 [TBL] [Abstract][Full Text] [Related]
10. Association Between Aggressive Clinicopathologic Features of Papillary Thyroid Carcinoma and Body Mass Index: A Systematic Review and Meta-Analysis. Economides A; Giannakou K; Mamais I; Economides PA; Papageorgis P Front Endocrinol (Lausanne); 2021; 12():692879. PubMed ID: 34276564 [TBL] [Abstract][Full Text] [Related]
11. Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma. Choi JS; Kim EK; Moon HJ; Kwak JY Endocrine; 2015 Feb; 48(1):264-71. PubMed ID: 24858734 [TBL] [Abstract][Full Text] [Related]
12. High expression of metadherin correlates with malignant pathological features and poor prognostic significance in papillary thyroid carcinoma. Li WF; Wang G; Zhao ZB; Liu CA Clin Endocrinol (Oxf); 2015 Oct; 83(4):572-80. PubMed ID: 25418110 [TBL] [Abstract][Full Text] [Related]
13. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter. Hou X; Jiang L; Chen C; Zhu X; Ge M Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079 [TBL] [Abstract][Full Text] [Related]
14. The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer. Gąsior-Perczak D; Pałyga I; Szymonek M; Kowalik A; Walczyk A; Kopczyński J; Lizis-Kolus K; Trybek T; Mikina E; Szyska-Skrobot D; Gadawska-Juszczyk K; Hurej S; Szczodry A; Słuszniak A; Słuszniak J; Mężyk R; Góźdź S; Kowalska A PLoS One; 2018; 13(10):e0204668. PubMed ID: 30273371 [TBL] [Abstract][Full Text] [Related]
15. Influence of body mass index on the clinicopathological features of 13,995 papillary thyroid tumors. Li CL; Dionigi G; Zhao YS; Liang N; Sun H J Endocrinol Invest; 2020 Sep; 43(9):1283-1299. PubMed ID: 32166701 [TBL] [Abstract][Full Text] [Related]
16. Correlation between body mass index and clinicopathological features of papillary thyroid microcarcinoma. Liu Z; Maimaiti Y; Yu P; Xiong Y; Zeng W; Li X; Song H; Lu C; Xin Y; Zhou J; Zhang N; Ming J; Liu C; Shi W; Shi L; Li X; Nie X; Huang T Int J Clin Exp Med; 2015; 8(9):16472-9. PubMed ID: 26629173 [TBL] [Abstract][Full Text] [Related]
17. Influence of Body Mass Index and Body Surface Area on the Behavior of Papillary Thyroid Carcinoma. Kim SK; Woo JW; Park I; Lee JH; Choe JH; Kim JH; Kim JS Thyroid; 2016 May; 26(5):657-66. PubMed ID: 26959390 [TBL] [Abstract][Full Text] [Related]
18. Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study. Cao J; Hu JL; Chen C; Wang QL; Fang XH; Zhang Y; Ge MH J Clin Pathol; 2016 Oct; 69(10):872-7. PubMed ID: 27010434 [TBL] [Abstract][Full Text] [Related]
19. Association of Preoperative US Features and Recurrence in Patients with Classic Papillary Thyroid Carcinoma. Kim SY; Kwak JY; Kim EK; Yoon JH; Moon HJ Radiology; 2015 Nov; 277(2):574-83. PubMed ID: 25955580 [TBL] [Abstract][Full Text] [Related]
20. [Association between body mass index and aggressiveness of papillary thyroid carcinoma]. Faure EN; Soutelo MJ; Fritz MC; Martín A; Musri Y; Lutfi R Medicina (B Aires); 2018; 78(3):145-150. PubMed ID: 29940539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]